Tzu-Hsiu Chen

Oncogenic Transformation by Inhibitor-Sensitive and -Resistant EGFR Mutants

Heidi Greulich, Tzu-Hsiu Chen, Whei Feng et al. · PLoS Medicine · 2005 · 683 citations · Full text

Medicine, Cancer Biology, Oncology +17

Drug-sensitive <i>FGFR2</i> mutations in endometrial carcinoma

Amit Dutt, Helga B. Salvesen, Tzu-Hsiu Chen et al. · Proceedings of the National Academy of Sciences · 2008 · 345 citations · Full text

Medicine, Cancer Biology, Oncology +17

Functional analysis of receptor tyrosine kinase mutations in lung cancer identifies oncogenic extracellular domain mutations of <i>ERBB2</i>

Heidi Greulich, Bethany Kaplan, Philipp Mertins et al. · Proceedings of the National Academy of Sciences · 2012 · 267 citations · Full text

Medicine, Molecular Biology, Oncology +17

Chemogenomic Profiling Provides Insights into the Limited Activity of Irreversible EGFR Inhibitors in Tumor Cells Expressing the T790M EGFR Resistance Mutation

Martin L. Sos, Haridas B. Rode, Stefanie Heynck et al. · Cancer Research · 2010 · 219 citations · Full text

Medicine, Oncology, Pharmacology +15

Allele-dependent variation in the relative cellular potency of distinct EGFR inhibitors

Yuki Yuza, Karen A. Glatt, Jingrui Jiang et al. · Cancer Biology & Therapy · 2007 · 86 citations

Medicine, Pharmacology, Cancer Pharmacology +9